RESEARCH-USE BIOSIMILAR ANTIBODY

Amatuximab

Monoclonal antibody · IgG1

MSLNIgG1RUO

Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium.

TARGETMSLN
YMonoclonal antibody
CATALOGSC-BS-772
CATALOG NUMBERSC-BS-772
MOLECULAR WEIGHTApprox. 144.363 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium.

Amatuximab is a recombinant research-use antibody directed against MSLN.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Amatuximab | StellaCyte